Skip to main navigation
Skip to search
Skip to main content
University of Bristol Home
Help & Terms of Use
Home
Profiles
Research units
Research Outputs
Projects
Student theses
Datasets
Activities
Prizes
Facilities/Equipment
Search by expertise, name or affiliation
Vaccine safety in the neonatal period
M. J. Day
Langford Third Party
Research output
:
Contribution to journal
›
Article (Academic Journal)
›
peer-review
16
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vaccine safety in the neonatal period'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Vaccine Efficacy
100%
Kitten
100%
Newborn Period
100%
Vaccine
100%
Auto-immunity
50%
Hypersensitive Response
50%
Type I Hypersensitivity
50%
Immunologic Adjuvant
50%
Immunoglobulin E Antibody
50%
Prevalence
50%
Breed
50%
Dog Breed
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Vaccine
100%
Erethism
66%
Structure Activity Relationship
66%
Kitten
66%
Disease
33%
Inflammation
33%
Prevalence
33%
Bovine Serum Albumin
33%
Immunoglobulin E Antibody
33%
Immunologic Adjuvant
33%
Dog Breed
33%